Skip to Content

Pitt, UPMC Announce $200 Million Immunotherapy Investment, Creation of Innovation Facility

The University of Pittsburgh and UPMC are once again partnering to advance the pace of life-changing innovation in the region and beyond.

Pitt and UPMC leaders today announced plans to establish the new UPMC Immune Transplant and Therapy Center (ITTC), with much of its activity planned within an eight-story innovation hub—all part of a concerted effort to harness the power of the human immune system to treat and cure a wide range of diseases.

As part of the collaboration, UPMC has made a $200 million commitment to ITTC, and the University will transform a century-old building at 5000 Baum Boulevard into a world-class space for labs, offices, startup companies, and industry partners.

Read the full press release here.


Click each image to view in high-resolution.

ITTC Baum Boulevard
Credit: University of Pittsburgh

A preliminary concept for 5000 Baum, as seen from the intersection of Morewood and Centre Avenues.

Rendering of immune cell attacking cells of a transplanted liver, which leads to organ rejection.

ITTC image

Rendering of anti-rejection medication suppressing the activity of an immune cell, preventing organ rejection.

ITTC image

Rendering of immune cells being suppressed by cancer cells.

ITTC image

Rendering of activated immune cells attacking cancer cells.

Credit: UPMC (above 4 images)